Matarin Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-69,882
| Closed | -$1.01M | – | 295 |
|
|
2017
Q3 | $1.01M | Hold |
69,882
| – | – | 0.09% | 195 |
|
|
2017
Q2 | $846K | Buy |
69,882
+49,593
| +244% | +$600K | 0.08% | 192 |
|
|
2017
Q1 | $261K | Buy |
+20,289
| New | +$261K | 0.03% | 256 |
|
|
2016
Q3 | – | Sell |
-44,720
| Closed | -$424K | – | 236 |
|
|
2016
Q2 | $424K | Sell |
44,720
-226,810
| -84% | -$2.15M | 0.06% | 203 |
|
|
2016
Q1 | $1.91M | Buy |
271,530
+31,367
| +13% | +$221K | 0.27% | 138 |
|
|
2015
Q4 | $2.51M | Buy |
240,163
+79,396
| +49% | +$830K | 0.38% | 116 |
|
|
2015
Q3 | $1.08M | Buy |
+160,767
| New | +$1.08M | 0.22% | 135 |
|